Clinical Trial Update: Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating patiromer to facilitate transitioning chronic kidney disease patients with hyperkalemia to a plant-rich diet; results posted a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperkalemia

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: NYU Langone Health | Conditions: Chronic Kidney Diseases, Hyperkalemia | Phase 4 | Status: COMPLETED | Results posted: 2021-12-01